David M. Ross, Paul A. Bartley, Jarrad Goyne, Alexander A. Morley, John F. Seymour, Andrew P. Grigg. Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features. haematol [Internet]. 2011Nov.4 [cited 2024Nov.22];96(11):1720-2. Available from: https://haematologica.org/article/view/6134